Publication | Closed Access
Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
178
Citations
19
References
2002
Year
Breast OncologyOncologyBreast CancerNeoadjuvant DocetaxelCancer TreatmentMedicineRadiation OncologyAberdeen Trial
| Year | Citations | |
|---|---|---|
Page 1
Page 1